Irinotecan, Continuous 5-Fluorouracil, and Low dose of Leucovorin (modified FOLFIRI) as First Line of Therapy in Recurrent or Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

Irinotecan, Continuous 5-Fluorouracil, and Low dose of Leucovorin (modified FOLFIRI) as First Line of Therapy in Recurrent or Metastatic Colorectal Cancer

Published:2005 Issue:3 Volume:20 Page:205
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Lee Myung-Ah¹,Byun Jae-Ho¹,Shim Byoung-Young¹,Woo In-Sook¹,Kang Jin-Hyung¹,Hong Young Seon¹,Lee Kyung Shik¹,Choi Myung Gyu¹,Chang Suk Kyun²,Oh Seong Taek²,Choi Sung Il³,Lee Doo Suk³

Affiliation:

1. Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.

2. Department of Surgery, The Catholic University of Korea College of Medicine, Seoul, Korea.

3. Department of Surgery, Dae Hang Hospital, Seoul, Korea.

Publisher

Korean Association of Internal Medicine

Link

http://synapse.koreamed.org/pdf/10.3904/kjim.2005.20.3.205

Reference17 articles.

1. Systemic treatment of colorectal cancer

2. Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

3. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

4. CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer

5. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the therapeutic promise of drug-repurposed-loaded nanocarriers: A pioneering strategy in advancing colorectal cancer treatment;International Journal of Pharmaceutics;2024-10

2. Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal cancer: A dual-targeted approach;International Journal of Biological Macromolecules;2020-05

3. Development of Quality Indicators of Care for Patients Undergoing Hepatic Resection for Metastatic Colorectal Cancer Using a Delphi Process;Journal of Surgical Research;2009-09